awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33819279-A54E8E79-818E-431E-8C45-985B1DAFAC21
Q33819279-A54E8E79-818E-431E-8C45-985B1DAFAC21
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33819279-A54E8E79-818E-431E-8C45-985B1DAFAC21
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
P2860
Q33819279-A54E8E79-818E-431E-8C45-985B1DAFAC21
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33819279-A54E8E79-818E-431E-8C45-985B1DAFAC21
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a3826d61977de729549f9e85fb34eed0edccf29
P2860
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard c